Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Latest News

Market capAny size
All Over $50MOver $300MOver $2BOver $10B
All Under $1BUnder $10BUnder $100BUnder $500B
SectorsAll
Filter by sector
Sunday, October 18, 2026· 10697 stock ideas· 217 writers·
18,401 views· 8,584 clicks

Semtech Analyst Day Review

Semtech raised Q3 guidance and targets $3.2 billion of fiscal 2030 revenue, excluding upside from its AI data-center optical and copper interconnect businesses.

SMTC $16B
CV's Substack 8 clicks

From X

@pennycheck 1 click

⚽️📡 on X

I really think this can be a meaningful catalyst for Blacksky Aside from it opening a new vertical and revenue stream, as well as a entirely new TAM. The social arbitrage when every retail investor realizes how cool this tech is and the company behind the imagery and the AI read through on what the images says can be extreme. It is rolling out at first 4 observation sets related to 24 companies but obviously that is only the beginning. I believe this can be the start of a broader inflection of blackskys role in the mega theme i've been discussing the past few months of the value of proprietary data to increase exponentially over the coming months and years as advanced AI capabilities make the value and ease of monetization of proprietary data extremely valueable which also leads into how $BKSY edge in gen-3 having 35cm over the 50cm of competitors planet and satellogic become all the more valuable as AI tools. Many of these data 'moat' stocks have begun to re-rate in the past few months and I think this release on robinhood could be the start of that inflection in the sat names with blacksky leading the way to the social arb aspect of being integrated into hood as mentioned earier. $BKSY is also starting to become a massive beneficiary of the sovereign space infra spend which i've discussed and highlighted before with a now robust pipeline on sovereign deals through 27' as they discussed on the call. They also have moonshot upside working with the Air Force on orbital data centers. Shorts have begun to cover but still have a looooong way to go 20% is still short and as you probably know I am not a big TA guy but even i can spot a triple bottom I think it's a decent risk/reward assuming mkt can hold up a bit here
@StableBread

Fajasy on X

Crean Hill cost Magna Mining $MGMNF (TSX: $NICU) US$11.3M in November 2022, and a 2024 preliminary study put the mine’s after-tax NPV at US$137.0M. If R2, the high-grade zone Magna found at its Levack mine, is Magna’s copper and precious metals upside, Crean Hill is its biggest nickel exposure. Crean Hill’s 2024 PEA (preliminary economic assessment) outlined a 13-year, 2,200 tonnes/day underground mine that sells its ore to a third-party mill: → Resource: 18.4Mt indicated at 1.01% nickel, 0.87% copper, and 2.47g/t platinum, palladium, and gold. → Capital: US$34.2M for an advanced exploration phase (early underground work and bulk mining before full production) that earns US$11.6M of revenue, then US$19.6M before commercial production. → Economics: After-tax NPV (at an 8% discount rate) of US$137.0M and a 129% IRR, at $8.50/lb nickel, $4.00/lb copper, $900/oz platinum, $1,000/oz palladium, and $2,150/oz gold. Weighting each metal’s price change by its share of PEA revenue, I estimate Crean Hill’s revenue would be ~32% higher at Q2 2026 prices, even though nickel, 51% of PEA revenue, is the only metal below its PEA price. CEO Jason Jessup says the pre-feasibility study (PFS), due in the first half of October, will use “more realistic consensus metal prices for 2026” and update the capital costs. He expects the PFS to come in “generally in line” with the PEA, with “some additional costs.” Jessup also said in July that Crean Hill’s capital is “not going to be anywhere near $140 million.” Unlike McCreedy West, Magna’s producing mine, Crean Hill carries no precious metals stream. To fund the restarts, Magna now has ~US$124M of cash, most of it from Alpayana, a Peruvian mining group that bought 19.9% of the company in August.
@ChrisCamillo 3 clicks

Chris Camillo on X

One of the most important disciplines in investing is constantly updating the best argument against your own position. Not dismissing it. Not looking for reasons it’s wrong. Actually understanding it well enough to decide how much conviction your own thesis deserves. $AMZN has badly lagged the market and many other AI names recently, and I think the counter thesis has evolved. The biggest new threat is agentic commerce. Meta’s Muse and other AI agents could increasingly control product discovery and purchasing, potentially weakening Amazon’s retail and advertising moat. That’s real. But I think it plays out slowly, Amazon will adapt through its own agents, including Project Moonraker, or partnerships that are seeking access into and monetization from the world’s largest ecommerce platform, and in an agent-first world the upside to AWS, Trainium, Graviton and Amazon’s broader AI infrastructure business could ultimately more than offset the advertising dollars at risk. Then there’s Anthropic. A recent barrage of negative headlines around slowing growth and Meta/Microsoft reducing Claude usage has spilled over into $AMZN sentiment. Again, worth taking seriously. But much of that narrative looks incomplete. Anthropic’s revenue growth remains extraordinary, its IPO appears very much alive, and its massive long term commitment to AWS remains intact. We are still early and one can make a strong argument that AWS has more to gain from an open source first AI world than it would lose from Anthropic’s and OAI’s relative weakness, if it even plays out that way. And now sharply higher diesel prices create another near term headwind to Amazon’s shipping margins. That’s real too. But either fuel prices normalize or as with past cost inflation Amazon eventually passes much of the higher cost through while continuing to drive down fulfillment costs. I don’t need the counter thesis to be wrong to own $AMZN. I just need the bull thesis to be more right.

Investor Letters

All letters

Free Recaps of the best new stock ideas, delivered every morning.

Read past recaps

2026.42: Home At Last

Stratechery’s weekly bundle covers Apple HomeView and SpaceX’s cellular ambitions.

AAPL $5T
Stratechery by Ben Thompson – On the business, strategy, and impact of technology. 4 clicks
ADCT · long

Adc Therapeutics SA (adct)

ADC Therapeutics centers on ZYNLONTA, an approved CD19-directed antibody-drug conjugate, after shares rose from roughly $4.

ADCT $189M
Value Investors Club

Is The Market Turning The Page?

CoreWeave’s debt and equity price action is framed as a wake-up call for investors amid a broader market discussion.

CRWV $34B
WHAT ARE WE DOING? “Contrarians At The Gate” 51 clicks

PesoRama: Research Flash

PesoRama will reach 54 JOi Dollar Plus stores by November after raising C$28.4 million, funding more than 50 additional Mexican store…

TBBB $6.8B
Atrium Research - Equity Research 6 clicks

Modine Deep Dive

Modine, soon Modexus Solutions, has a $4 billion hyperscaler cooling contract but must ramp factory output and restore margins as data…

MOD $9.2B
CV's Substack 18 clicks

AppLovin Deep Dive

AppLovin rebuilt its ad model with AXON 2.0, lifting LTM revenue to about $7 billion and margins to 77% as Unity competition threatens…

APP $88B
Speedwell Research 25 clicks

Have a source we’re missing? Send your pick

Recent recaps

Latest recap

Saturday, October 17 31 stock ideas
  • SiriusXM: Dirt Cheap, Looming Catalysts, Short Squeeze Candidate Eagle Point Capital
  • Expert Call | Q3 2026 Optical Components Market Dynamics, Vendor Market Share, & 2027 Growth Outlook P Equity Research
Read the recap

All recaps

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 107

YouTube 4

Blogs 17

Seeking Alpha 52 of 238

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

88 accounts
Nominate an account

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.

Anything we’re missing?

Send us a pick